Molecular biology in acute leukemia

被引：4

作者：

Camós M. ^{[1
]}

Colomer D. ^{[1
]}

机构：

[1] Unitat d'Hematopatologia, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona

来源：

Clinical and Translational Oncology | 2006年 / 8卷 / 8期

关键词：

Acute lymphoblastic leukemia; Acute myeloid leukemia; Molecular biology;

D O I：

10.1007/s12094-006-0060-6

中图分类号：

学科分类号：

摘要：

Acute leukemia is a clonal expansion of tumoral cells in bone marrow, blood or other tissues. The acute leukemias are classified as myeloid or lymphoid based on the lineage of the blast cells. Over the past three decades, remarkable advances have been made in the classification and treatment of acute leukemias. In the last years, the research into the molecular pathogenesis of acute leukemia has progressed. The knowledge of chromosomal translocations breakpoints and possible candidate oncogenes and tumor suppressor genes has allowed the integration of all these events into multistep cascades that impact specific signal transduction pathways and lead to leukemic transformation. © FESEO 2006.

引用

页码：550 / 559

页数：9

共 88 条

[1] Lowenberg B., Downing J.R., Burnett A., Acute myeloid leukemia, N Engl J Med, 341, pp. 1051-1062, (1999)
[2] Grimwade D., Walker H., Oliver F., Et al., The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties, Blood, 92, pp. 2322-2355, (1998)
[3] Mrozek K., Heerema N.A., Bloomfield C.D., Cytogenetics in acute leukemia, Blood Rev, 18, pp. 115-136, (2004)
[4] Frohling S., Scholl G., Gilliand D.G., Levine R.L., Genetics of myeloid malignancies: Pathogenetic and clinical implications, J Clin Oncol, 25, pp. 6285-6295, (2005)
[5] Mrozek K., Heinonen K., Bloomfield C.D., Clinical importance of cytogenetics in acute myeloid leukaemia, Best Pract Res Clin Haematol, 14, pp. 19-47, (2001)
[6] Blyth K., Cameron E.R., Neil J.C., The RUNX genes: Gain or loss of function in cancer, Nat Rev Cancer, 5, pp. 576-587, (2005)
[7] Pabst T., Mueller B.U., Zhang P., Et al., Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia, Nat Genet, 27, pp. 265-270, (2001)
[8] Linggi B., Mull-Tidow G., Pavan de L.L., Et al., The t(8l
[9] 21) fusion protein, AML1 ETO, specifically represses the transcription of the P14(ARF) tumor suppressor in acute myeloid leukemia, Nat Med, 8, pp. 743-750, (2002)
[10] Durst K.L., Lutterbach B., Kummalue T., Friedman A.D., Hiebert S.W., The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavychain domain, Mol Cell Biol, 25, pp. 607-619, (2005)

← 1 2 3 4 5 6 7 8 9 →